Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids
about
Targeted gene disruption to cure HIVIn vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle deliveryImproved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.Transmembrane protein aptamers that inhibit CCR5 expression and HIV coreceptor functionEfficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.RNA interference approaches for treatment of HIV-1 infectionNanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epitheliumThe therapeutic application of CRISPR/Cas9 technologies for HIV.Local delivery of gene-modifying triplex-forming molecules to the epidermis.Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells.Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice.Bacterial cellular engineering by genome editing and gene silencingEliminating the HIV reservoir.Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.Cell-based gene therapy against HIV.Nanotechnology for delivery of peptide nucleic acids (PNAs)Design of Tail-Clamp Peptide Nucleic Acid Tethered with Azobenzene Linker for Sequence-Specific Detection of Homopurine DNA.[A new toolbox for genome editing].Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
P2860
Q27023171-7F3B6E29-E446-48BA-915E-FC5AB6CE21D5Q30051830-3B8799C1-D3D0-4236-947D-07275EA0DB4BQ33584005-90879451-9278-4DA8-99C3-318943CCFAA2Q34343448-E9EAE8E5-1714-4B33-A373-AB3DF124436CQ34727851-DDAC36BB-393C-474E-A99E-D7832B19DE51Q35097053-6B720CB5-EE13-4ABA-AB3F-23E65E8B7179Q35652119-35FD3E42-41A0-4F51-8FE7-77C85B9E7BBAQ35781735-B25017F2-FAA4-45FB-B8F8-1E7A33BC6EC0Q36089328-56ED1C33-9370-4C63-968C-44056BC8527EQ36494745-80E55CB3-B70A-480E-9D1A-D9302530E5FEQ36659260-06F6B4A7-63CF-40E7-9893-D35F4FB3FC2EQ37019421-268CF3AE-0CB2-4BE2-8D7C-4BD36DCA80E6Q37167989-0A60C5FB-7B71-4839-9898-B811BC546174Q37467837-0862F0D9-1EC2-4EB6-9E71-1668BFADD1EFQ37645309-330FA4BE-1379-4934-9EAD-21B532C8C82EQ37993454-7EF05C6D-F091-48D2-9BC0-0264B49D5833Q38462651-DED2E756-7B9E-4CDE-BA4B-7604674CD858Q38529069-1B393347-7DFC-4E1D-B567-04FCD56B35F4Q38699488-C45F5FB6-B341-456C-B896-2D394FBC8BE1Q47595872-8C93FA25-AED4-4843-A798-6DAA1971890DQ48638209-1A9909F7-CFFC-4980-9371-38D633F08562Q52657758-6F07342D-E518-4C5D-A9B2-51086E1BE80CQ52743737-15E53EA8-B6F4-44B0-BEDC-424BA27DAB5D
P2860
Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@ast
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@en
type
label
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@ast
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@en
prefLabel
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@ast
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@en
P2093
P2860
P1476
Targeted disruption of the CCR ...... lated by peptide nucleic acids
@en
P2093
Dale L Greiner
Erica B Schleifman
Faye A Rogers
Jacob del Campo
Leonard D Shultz
Peter M Glazer
Pradeep Uchil
Priti Kumar
Ranjit Bindra
P2860
P304
P356
10.1016/J.CHEMBIOL.2011.07.010
P50
P577
2011-09-01T00:00:00Z